Ind-Swift Laboratories Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
28 Sep 2026Essix Biosciences Limited
Reg29(2)
Acquisition Preferential Allotment 0
0.00%
— 37.81% Yes
22 Apr 2026HCP Investments
Reg29(2)
Sale Open Market — 6,503,423
7.50%
1.15% No
27 Feb 2026Essix Biosciences Limited
Reg29(2)
Acquisition Preferential Allotment 5,100,000
5.88%
— 37.92% Yes
29 Aug 2025Mrs. Divya Munjal
Reg29(2)
Acquisition Others 2,250
0.01%
— 0.01% Yes
29 Aug 2025Mr. Daksh Mehta
Reg29(2)
Acquisition Others 150
0.00%
— 0.00% Yes
29 Aug 2025Mr. Gopal Munjal
Reg29(2)
Acquisition Others 293,579
0.28%
— 0.43% Yes
29 Aug 2025Mr. S. R. Mehta
Reg29(2)
Acquisition Others 305,380
0.37%
— 0.66% Yes
29 Aug 2025Mrs. Sunita Jain
Reg29(2)
Acquisition Others 271,860
0.33%
— 0.39% Yes
29 Aug 2025Essix Biosciences Limited
Reg29(2)
Acquisition Others 2,555,014
3.13%
— 34.04% Yes
29 Aug 2025Mrs. Neera Mehta
Reg29(2)
Acquisition Others 232,057
0.28%
— 0.59% Yes

Showing the most recent disclosures only. Sign in to see more, or upgrade your plan to see the full history. Sign in

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.